title: [Abuse of opioid therapy in somatoform pain disorder. A contribution from a psychosomatic/pain therapist point of view to the discussion of the indication of opioids in nonmalignant pain based on 8 cases].
abstract: We report 8 in-patients with nonmalignant chronic pain (main diagnosis: 7 somatoform pain disorders, 1 eating disorder) and with abuse of opioid therapy, which we have treated within 2 years in an tertiary centre. In all patients the inefficacy of opioids with regard to pain symptomatology could be demonstrated. Because the ICD-10 criteria of addiction cannot be fully applied to patients under opioid therapy because of chronic pain we suggest as criteria the intake of opioids because of positive psychotropic effects, the demand of high dosage of short acting opioids with inefficacy of similar long acting opioids dosage, the uncontrolled raising of dosage with illegal procurement and reluctance of the patient to stop opioid therapy because of proved inefficacy of pain control. These criteria applied 4% of all in-patients treated because of chronic pain and 30% of all in patients with somatoform pain disorder of our interdisciplinary unit fulfilled within two years the criteria of opioid therapy abuse. The risk of abuse of opioid therapy described in pain therapy literature for patients with substance abuse is also relevant for patients with somatoform pain disorder. Therefore a qualified psychotherapeutic evaluation before starting an opioid therapy for nonmalignant pain in order to exclude a somatoform pain disorder or to assess a substance dependency is mandatory. Patients with somatoform pain disorder should be treated with opioids only in clinical studies. A prior or present history of substance abuse given chronic opioid therapy for nonmalignant pain should only be performed in close cooperation of addiction- and pain therapists.
authors.affiliation: Medizinische Klinik I (Gastroenterologie, Hepatologie, Stoffwechsel- und Infektionskrankheiten - Funktionsbereich Psychosomatik), Klinikum Saarbrücken gGmbH, Saarbrücken. w.haeuser@klinikum-saarbruecken.de
authors.forename: S
authors.initials: S
authors.lastname: Wambach
authors.forename: P
authors.initials: P
authors.lastname: Rohr
authors.forename: W
authors.initials: W
authors.lastname: Häuser
mesh_terms: D000328:Adult; D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000009:adverse effects*; D002908:Chronic Disease; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008875:Middle Aged; D009293:Opioid-Related Disorders / Q000175:diagnosis / Q000209:etiology*; D010146:Pain / Q000188:drug therapy*; D018710:Pain Clinics; D010147:Pain Measurement; D010348:Patient Care Team; D012307:Risk Factors; D013001:Somatoform Disorders / Q000188:drug therapy*; D017211:Treatment Failure
chemical_list: D000701:Analgesics, Opioid